InspireMD (NSPR) Non Operating Income (2010 - 2025)
InspireMD's (NSPR) quarterly Non Operating Income came in at $386000.0 in Q4 2025, up 53.17% year-on-year from $252000.0 in Q4 2024, and up 12.54% quarter-over-quarter from $343000.0 in Q3 2025.
InspireMD (NSPR) Non Operating Income (2010 - 2025) Analysis & Trends
InspireMD's Non Operating Income history runs 16 years deep, the most recent figure standing at $386000.0 for Q4 2025.
- On a quarterly basis, Non Operating Income rose 53.17% year-over-year to $386000.0 in Q4 2025; TTM through Dec 2025 was $891000.0, a 42.77% decrease from a year earlier, with the FY2025 full-year figure at $891000.0, down 42.77% from the prior year.
- Non Operating Income climbed to $386000.0 in Q4 2025 per NSPR's latest filing, from $343000.0 in the prior quarter.
- Across five years, Non Operating Income topped out at $572000.0 in Q3 2024 and bottomed at -$132000.0 in Q2 2025.
- The 5-year median for Non Operating Income is $181500.0 (2023), against an average of $191650.0.
- Across the five-year window, Non Operating Income soared 2400.0% in 2023 and plunged 137.61% in 2025, its largest moves.
- Year by year, Non Operating Income stood at -$121000.0 in 2021, then soared by 198.35% to $119000.0 in 2022, then surged by 293.28% to $468000.0 in 2023, then tumbled by 46.15% to $252000.0 in 2024, then jumped by 53.17% to $386000.0 in 2025.
- Per Business Quant, the three latest NSPR Non Operating Income figures stand at $386000.0 (Q4 2025), $343000.0 (Q3 2025), and -$132000.0 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 62.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -18.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | InspireMD | 2,073.45 | -54.21 Mn | 1.18 Mn | 386,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 386,000.00 |
| Sep 30, 2025 | 343,000.00 |
| Jun 30, 2025 | -132,000.00 |
| Mar 31, 2025 | 294,000.00 |
| Dec 31, 2024 | 252,000.00 |
| Sep 30, 2024 | 572,000.00 |
| Jun 30, 2024 | 351,000.00 |
| Mar 31, 2024 | 382,000.00 |
| Dec 31, 2023 | 468,000.00 |
| Sep 30, 2023 | 461,000.00 |
| Jun 30, 2023 | 238,000.00 |
| Mar 31, 2023 | 125,000.00 |
| Dec 31, 2022 | 119,000.00 |
| Sep 30, 2022 | 81,000.00 |
| Jun 30, 2022 | 45,000.00 |
| Mar 31, 2022 | 5,000.00 |
| Dec 31, 2021 | -121,000.00 |
| Sep 30, 2021 | -40,000.00 |
| Jun 30, 2021 | -67,000.00 |
| Mar 31, 2021 | 71,000.00 |